Brolucizumab - CISMeF

Preferred Label : Brolucizumab;

UNII : XSZ53G39H5;

CAS number : 1531589-13-5;

NCI Metathesaurus CUI : CL1382174;

Origin ID

C169818;

UMLS CUI

C4550124;

CISMeF manual mappings
- brolucizumab [MeSH concept]
Currated CISMeF NLP mapping
- Brolucizumab [SMS substance]
- Brolucizumab (substance) [SNOMED CT concept]
- brolucizumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Brolucizumab (substance) [SNOMED CT concept]
- Product containing brolucizumab (medicinal product) [SNOMED CT concept]
- brolucizumab [MeSH Supplementary Concept]
- brolucizumab [ATC Code]
Validated automatic mappings to BTNT
- brolucizumab [ATC Code]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]